Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04152122
Other study ID # 2016MEKY032
Secondary ID
Status Completed
Phase
First received
Last updated
Start date February 1, 2017
Est. completion date June 1, 2018

Study information

Verified date November 2019
Source Zhongshan Ophthalmic Center, Sun Yat-sen University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

A novel dynamic random-dot stereopsis test that included motion + disparity (MD), motion (M), and disparity (D), in which the disparity cues range from 200 to 1200 arc-seconds was used. The characteristics of preoperative dynamic stereopsis in 83 intermittent exotropia patients and its associations with clinical features were analysed, and the prognosis was followed up on the 1st day and 2nd, 6th and 12nd months postoperatively.


Recruitment information / eligibility

Status Completed
Enrollment 133
Est. completion date June 1, 2018
Est. primary completion date June 1, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 5 Years to 30 Years
Eligibility Inclusion Criteria:

X(T) groups were as follows:

1. near and distance exodeviation angles greater than 5 prism degrees (PD) and alternate cover tests and X(T) diagnosis by an experienced doctor;

2. between 5 and 30 years old;

3. 0.0 or better best corrected visual acuity (BCVA; logMAR, log of the minimum angle of resolution);

4. absence of other ocular disorders or other systemic diseases.

Normal group were as follows:

1. between 5 and 30 years old;

2. 0.0 or better logMAR BCVA;

3. near and distance exodeviation angles less than 5 PD and alternate cover tests; and

4. no history of any ocular pathology or systemic disease.

Exclusion Criteria:

X(T) groups were as follows:

1. near and distance exodeviation angles less than 5 prism degrees (PD)

2. younger than 5 or older than 30 years old;

3. less than 0.0 or better best corrected visual acuity (BCVA; logMAR, log of the minimum angle of resolution);

4. has other ocular disorders or other systemic diseases.

Normal group were as follows:

1. younger than 5 or older than 30 years old;

2. less than 0.0 or better best corrected visual acuity (BCVA; logMAR, log of the minimum angle of resolution);

3. near and distance exodeviation angles more than 5 PD and alternate cover tests;

4. has history of any ocular pathology or systemic disease.

Study Design


Related Conditions & MeSH terms

  • Dynamic Stereopsis in Intermittent Exotropia Patients
  • Exotropia

Intervention

Diagnostic Test:
The dynamic stereopsis test
The characteristics of preoperative dynamic stereopsis in 83 intermittent exotropia patients and its associations with clinical features were analysed, and the prognosis was followed up on the 1st day and 2nd, 6th and 12nd months postoperatively.

Locations

Country Name City State
China Zhongshan Opthalmic Center Guangzhou Guangdong

Sponsors (1)

Lead Sponsor Collaborator
Zhongshan Ophthalmic Center, Sun Yat-sen University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary The mean reciprocal value of stereopsis The mean reciprocal value of stereopsis on the 1st day 1st day
Primary The mean reciprocal value of stereopsis The mean reciprocal value of stereopsis on the 2nd month 2nd month
Primary The mean reciprocal value of stereopsis The mean reciprocal value of stereopsis on the 6th month 6th month
Primary The mean reciprocal value of stereopsis The mean reciprocal value of stereopsis on the 6th month 12th month